Controversy on the role of FoxP3 + regulatory T cells in fibrogenesis in chronic hepatitis C virus infections
2014
Factors predicting survival after post-transplant hepatocellular carcinoma recurrence. J Hepatobiliary Pancreat Sci 2013;20:342–347. [6] Waghray A, Balci B, El-Gazzaz G, Kim R, Pelley R, Narayanan MK, et al. Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation. Clin Transplant 2013;27:555–561. Carlo Sposito Vincenzo Mazzaferro⇑ The Hepato-Oncology Group, Gastro-Intestinal Surgery, Liver Transplantation and Hepatology – Fondazione IRCCS Istituto Nazionale Tumori, via Venezian 1, 20133 Milan, Italy ⇑Corresponding author. E-mail address: vincenzo.mazzaferro@istitutotumori.mi.it JOURNAL OF HEPATOLOGY
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
16
References
0
Citations
NaN
KQI